Parkinson's disease: Cause factors, measurable indicators, and early diagnosis

被引:120
|
作者
Bhat, Shreya [1 ]
Acharya, U. Rajendra [2 ,3 ,4 ]
Hagiwara, Yuki [2 ]
Dadmehr, Nahid
Adeli, Hojjat [5 ,6 ,7 ]
机构
[1] Manipal Inst Technol, Dept Biomed Engn, Manipal 576104, Karnataka, India
[2] Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore
[3] SUSS Univ, Sch Sci & Technol, Dept Biomed Engn, Singapore 599491, Singapore
[4] Taylors Univ, Sch Med, Fac Hlth & Med Sci, Subang Jaya, Malaysia
[5] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA
[6] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA
[7] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA
关键词
Parkinson's disease; Genes; LRRK2; Substantia nigra; PINK1; Neuroimaging; GBA; EMOTIONAL STATE CLASSIFICATION; NEURAL-NETWORK; AUTOMATED DETECTION; EEG; MUTATIONS; SYSTEM; FEATURES; BRAIN; IDENTIFICATION; DEPRESSION;
D O I
10.1016/j.compbiomed.2018.09.008
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disease of the central nervous system caused due to the loss of dopaminergic neurons. It is classified under movement disorder as patients with PD present with tremor, rigidity, postural changes, and a decrease in spontaneous movements. Comorbidities including anxiety, depression, fatigue, and sleep disorders are observed prior to the diagnosis of PD. Gene mutations, exposure to toxic substances, and aging are considered as the causative factors of PD even though its genesis is unknown. This paper reviews PD etiologies, progression, and in particular measurable indicators of PD such as neuroimaging and electrophysiology modalities. In addition to gene therapy, neuroprotective, pharmacological, and neural transplantation treatments, researchers are actively aiming at identifying biological markers of PD with the goal of early diagnosis. Neuroimaging modalities used together with advanced machine learning techniques offer a promising path for the early detection and intervention in PD patients.
引用
收藏
页码:234 / 241
页数:8
相关论文
共 50 条
  • [31] Development of early diagnosis of Parkinson's disease: Illusion or reality?
    Ugrumov, Michael
    CNS NEUROSCIENCE & THERAPEUTICS, 2020, 26 (10) : 997 - 1009
  • [32] Introducing a New Method for Early Diagnosis of Parkinson's Disease
    Sarbaz, Yashar
    Gharibzadeh, Shahriar
    Soltanzadeh, Akbar
    Towhidkhah, Farzad
    Banaie, Masood
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 24 (03) : E10 - E10
  • [33] Biomarkers in Parkinson's Disease: From Pathophysiology to Early Diagnosis
    Calabresi, Paolo
    Standaert, David G.
    Chiasserini, Davide
    Parnetti, Lucilla
    MOVEMENT DISORDERS, 2016, 31 (06) : 769 - +
  • [34] Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Le, Weidong
    Dong, Jie
    Li, Song
    Korczyn, Amos D.
    NEUROSCIENCE BULLETIN, 2017, 33 (05) : 535 - 542
  • [35] Electrogastrography for diagnosis of early-stage Parkinson's disease
    Araki, Nobuyuki
    Yamanaka, Yoshitaka
    Poudel, Anupama
    Fujinuma, Yoshikatsu
    Katagiri, Akira
    Kuwabara, Satoshi
    Asahina, Masato
    PARKINSONISM & RELATED DISORDERS, 2021, 86 : 61 - 66
  • [36] The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease
    Pawlik, Patrycja
    Blochowiak, Katarzyna
    DIAGNOSTICS, 2021, 11 (02)
  • [37] Cost factors of early diagnostics and pharmacotherapy of Parkinson's disease
    Kuchinke, B. A.
    Akmaz, B.
    Janetzky, W.
    NERVENHEILKUNDE, 2012, 31 (11) : 844 - 849
  • [38] Prenatal and Early Life Factors and Risk of Parkinson's Disease
    Gardener, Hannah
    Gao, Xiang
    Chen, Honglei
    Schwarzschild, Michael A.
    Spiegelman, Donna
    Ascherio, Alberto
    MOVEMENT DISORDERS, 2010, 25 (11) : 1560 - 1567
  • [39] Prenatal and early life factors and risk of Parkinson's disease
    Gardener, Hannah E.
    Chen, Honglei
    Xiang, Gao
    Schwarzschild, Michael
    Spiegelman, Donna
    Ascherio, Alberto
    NEUROLOGY, 2008, 70 (11) : A191 - A191
  • [40] Effect of adding selegiline to levodopa in early, mild Parkinson's disease - Parkinson's disease is rarely a primary cause of death
    Silva, M
    Watts, PM
    Jenner, P
    BRITISH MEDICAL JOURNAL, 1996, 312 (7032): : 703 - 703